高维倾向性评分调整的病例交叉设计用于药物警戒信号检测
该研究提出并评估一种结合病例交叉设计与高维数据驱动变量选择构建的倾向性评分的药物警戒信号检测新方法,通过模拟和法国国家健康数据库4099例急性心肌梗死患者的真实数据分析,与单变量和LASSO病例交叉方法比较。结果显示新方法在控制错误发现率方面优于单变量方法,性能与LASSO相似,识别出43个信号中51%具有潜在药理学相关性。
要点
- 新方法结合病例交叉与高维倾向性评分,可控制未测量的时不变混杂。
- 模拟中错误发现率控制在预设水平,单变量方法则不能。
- 真实数据中43/609个信号被认为潜在药理学相关,其中16%高度相关。
核心结论
- 倾向性评分结合病例交叉设计对药物警戒信号检测具有价值。
- 在挖掘医疗行政数据库时,适应症偏倚仍是挑战。
研究设计与样本
- 方法学研究,通过模拟和真实数据研究比较新方法与单变量及LASSO病例交叉方法。
- 真实数据研究分析法国国家健康数据库中4099例急性心肌梗死患者,由两名药物安全专家评估信号。
主要发现
- 模拟中,新方法对信号的排序与LASSO相似,优于单变量方法,并将错误发现率控制在预设水平。
- LASSO灵敏度最佳但错误发现率估计较大。
- 真实数据应用中,新方法性能与LASSO相似,优于单变量方法。
- 新方法从609个候选药物中突出43个信号,其中22个(51%)被认为潜在药理学相关,7个(16%)被视为高度相关。
关键数值与推荐
- 单变量和倾向性评分调整的病例交叉方法的检测阈值基于错误发现率程序。
- LASSO的检测阈值基于赤池信息准则。
临床怎么用
- 可考虑将倾向性评分调整的病例交叉设计用于医疗行政数据库的药物警戒信号检测。
- 在信号挖掘中需注意适应症偏倚的影响。
局限性
- 适应症偏倚仍是医疗行政数据库挖掘中的挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Increasing availability of medico-administrative databases has prompted the development of automated pharmacovigilance signal detection methodologies. Self-controlled approaches have recently been proposed. They account for time-independent confounding factors that may not be recorded. So far, large numbers of drugs have been screened either univariately or with LASSO penalized regressions. OBJECTIVE: We propose and assess a new method that combines the case-crossover self-controlled design with propensity scores (propensity score-adjusted case-crossover) built from high-dimensional data-driven variable selection, to account for co-medications or possibly other measured confounders. METHODS: Comparison with the univariate and LASSO case-crossover was performed from simulations and a real-data study. Multiple regressions (LASSO, propensity score-adjusted case-crossover) accounted for co-medications and no other covariates. For the univariate and propensity score-adjusted case-crossover methods, the detection threshold was based on a false discovery rate procedure, while for LASSO, it relied on the Akaike Information Criterion. For the real-data study, two drug safety experts evaluated the signals generated from the analysis of 4099 patients with acute myocardial infarction from the French national health database. RESULTS: On simulations, our approach ranked the signals similarly to the LASSO and better than the univariate method while controlling the false discovery rate at the prespecified level, contrary to the univariate method. The LASSO provided the best sensitivity at the cost of larger false discovery rate estimates. On the application, our approach showed similar performances to the LASSO and better performances than the univariate method. It highlighted 43 signals out of 609 drug candidates: 22 (51%) were considered as potentially pharmacologically relevant, including seven (16%) regarded as highly relevant. CONCLUSIONS: Our findings show the interest of a propensity score combined with a case-crossover for pharmacovigilance. They also confirm that indication bias remains a challenge when mining medico-administrative databases.
引用
- Volatier E, Salvo F, Pariente A, et al. High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare Databases. Drug Saf. 2022. PMID: 35179704. doi:10.1007/s40264-022-01148-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。